Dr. Rachel Tate uptoTate
5 years 4 months ago
Does it matter if you diagnose a symptomatic pt w/ nr-axSpA vs r-axSpA? (2/2) Interestingly there are smaller deltas between ASAS40 results in PBO vs nr-axSpA compared to axSpA vs PBO in MEASURE 2, PREVENT, COAST-V, COAST-X, RAPID, C-axSpAnd. Dr. Deodhar #EULAR2021 @RheumNow https://t.co/V8zlZdGltQ
k dao KDAO2011
5 years 4 months ago
"50% of time spent in LLDAS = 50% less damage accrual"- Prof E Morand reviews data on low disease activity state in lupus https://t.co/FU3hPvuyRU
k dao KDAO2011
5 years 4 months ago
Prof Van Vollenhoven reveals the Definition of Remission in SLE (DORIS 2021): treating SLE to target #EULAR2021 @rheumnow
👉SLEDAI=0
👉MD global<0.5
👉dsDNA, C3/C4 does not matter
👉prednisone <=5 mg/d, stable meds
👉remission can be met at any point (duration not required https://t.co/TwusJkXR19
Dr. Rachel Tate uptoTate
5 years 4 months ago
Does it matter if you diagnose a symptomatic patient with nr-axSpA vs radiographic axSpA? (1/2)Dr. Deodhar discusses differences in tx withdrawal/dose reduction(PBO) shown in RE-EMBARK, ABILITY-3, C-OPTIMISE. #EULAR2021 @RheumNow https://t.co/wVYsPYFLAi
Janet Pope Janetbirdope
5 years 4 months ago
MUC5B variant gene in 5634 RA pts had 2X ⬆️ risk of RA ILD - same gene as in IPF. Clinical relevance is unknown but could it result in a novel Rx pathway? ? Effect of sex & smoking @RheumNow @eular_org abst OP0007 #EULAR2021 https://t.co/8XpKjPFfUX
Janet Pope Janetbirdope
5 years 4 months ago
To clot or NOT? Real world data usually show no ⬆️ VTE in RA with #Jaki compares to other advanced therapies. Diff from high CV risk pts in Oral Surveillance where Tofacitinib had higher VTE vs TNFi @AbbVie symposium @eular_org #EULAR2021 @RheumNow Hard to reconcile diff risk. https://t.co/AWY2zZPSIb
Dr. Rachel Tate uptoTate
5 years 4 months ago
Dr. Deodhar reviews ASAS imaging/clinical classification and defines nrAxSpA at #EULAR2021 @RheumNow https://t.co/OdlQvGyNfY
k dao KDAO2011
5 years 4 months ago
Introducing EULAR's new name: 'European Alliance of Associations for Rheumatology' highlighting the importance of collaboration in the scientific community and bringing the patient’s voice across all bodies of work #EULAR2021 @rheumnow
Janet Pope Janetbirdope
5 years 4 months ago
Andrew Ostor @AbbVie symposium @eular_org presented HZ vaccines are safe in RA pts with #JAKi but with Recombinant HZ vaccine humeral response - 75% in RA pts in JAKi vs 100% controls. So should we hold JAKi with Shringix & if so for 1 or 2 wks? #EULAR2021 @RheumNow https://t.co/wVOFMa9fLm
Janet Pope Janetbirdope
5 years 4 months ago
Lifetime risk of HZ is 30%! ⬆️ in pts with immune diseases or immunesuppression. All #JAKI ⬆️ risk maybe doubling but NNH & NNT give context. UPA Rx in active RA -20 more pts in remission vs 1 excess HZ if comparing UPA to ADA in RA @RheumNow #EULAR2021 AbbVie symposium https://t.co/14i0IsIpzs
Janet Pope Janetbirdope
5 years 4 months ago
Do you think JAKi cause VTE? @eular_org @RheumNow #EULAR2021
Janet Pope Janetbirdope
5 years 4 months ago
Do you think #JAKI ⬆️ #MACE cardiovascular events vs TNFi? @eular_org @RheumNow #EULAR2021
k dao KDAO2011
5 years 4 months ago
"We can be soloist or collaborators." - Mark Pollock, keynote speaker #EULAR2021, inspires people to build resilience and collaborate w/others to achieve more than they thought possible. He was the 1st blind person to race to the South Pole @RheumNow https://t.co/qYpBr1I9US
RheumNow has begun covering EULAR 2021, the premier Rheumatology Congress that is usually held in Europe, but has gone virtual in 2021 because of the pandemic. We have several faculty members around the world reporting on the this year's meeting.
Please visit RheumNow.com daily for the latest videos, tweet summaries, news articles and podcasts emanating from EULAR.
Look for our coverage on these and other important topics:
Dr. John Cush RheumNow
5 years 4 months ago
New download available!
Difficult RA Defined
https://t.co/6WGMEiwiUk https://t.co/VTCm4cuyRe
